$eFFECTOR Therapeutics(EFTR.US)$eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer 2 MINUTES AGO, 8:30 AM EDT VIA GLOBENEWSWIRE EFTR SHARE SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader...
eFFECTOR Therapeutics股票討論區
I guess my GRRRR was warranted
Grrrr! Read last paragraph close!
T 1 News halt!
暫無評論